Outcome of Patients With Prior Percutaneous Revascularization Undergoing Repeat Coronary Intervention (from the PRESTO Trial)

Patients with previous percutaneous coronary intervention (PCI) are often excluded from clinical trials. As a result, limited data are available on the long-term outcome of such patients undergoing repeat PCI. In this study, we assessed the impact of previous PCI on outcomes in patients undergoing r...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2005-09, Vol.96 (6), p.741-746
Main Authors: Arjomand, Heidar, Willerson, James T., Holmes, David R., Bamlet, William R., Surabhi, Satish K., Roukoz, Bassam, Espinoza, Andrey, McClelland, Robyn L., McCormick, Daniel J., Goldberg, Sheldon
Format: Article
Language:English
Subjects:
Angioplasty, Balloon, Coronary - adverse effects
Biological and medical sciences
Cardiology
Cardiology. Vascular system
Clinical outcomes
Coronary Restenosis - prevention & control
Coronary Restenosis - therapy
Coronary Stenosis - therapy
Death, Sudden, Cardiac - prevention & control
Disease-Free Survival
Double-Blind Method
Female
Humans
Male
Medical sciences
Medical treatment
Middle Aged
Myocardial Infarction - prevention & control
Myocardial Infarction - therapy
Retreatment
Time Factors
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Patients with previous percutaneous coronary intervention (PCI) are often excluded from clinical trials. As a result, limited data are available on the long-term outcome of such patients undergoing repeat PCI. In this study, we assessed the impact of previous PCI on outcomes in patients undergoing repeat PCI. We compared the baseline features and outcomes of 7,056 patients without previous PCI (group I) with those of 1,281 patients with previous PCI of the original target lesion (group II) and 1,408 patients with previous PCI of a nontarget lesion (group III) undergoing PCI in the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial. Compared with patients in group I, patients in groups II and III were more likely to have diabetes (25% and 24% vs 21%, p
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2005.05.013